康芝药业：止咳橘红颗粒增加新功能主治临床试验申请获批准

Core Viewpoint - Kangzhi Pharmaceutical (300086.SZ) has received approval from the National Medical Products Administration for clinical trials of its "Cough Orange Granules" for use in acute exacerbations of chronic obstructive pulmonary disease (COPD) [1] Group 1 - The product "Cough Orange Granules" is already in production and on sale [1] - It was previously classified as a national secondary protected traditional Chinese medicine [1]